conivaptan has been researched along with nelfinavir in 1 studies
Studies (conivaptan) | Trials (conivaptan) | Recent Studies (post-2010) (conivaptan) | Studies (nelfinavir) | Trials (nelfinavir) | Recent Studies (post-2010) (nelfinavir) |
---|---|---|---|---|---|
188 | 17 | 64 | 1,240 | 230 | 240 |
Protein | Taxonomy | conivaptan (IC50) | nelfinavir (IC50) |
---|---|---|---|
Tyrosine-protein kinase Fyn | Homo sapiens (human) | 7.971 | |
Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 8.852 | |
ATP-dependent translocase ABCB1 | Homo sapiens (human) | 3.3938 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 1.275 | |
ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | 2.3 | |
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 8.852 | |
Protease | Human immunodeficiency virus 1 | 0.53 | |
Protease | Human immunodeficiency virus 1 | 0.0054 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for conivaptan and nelfinavir
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |